Cell MedX Corp. (OTCMKTS:CMXC – Get Free Report)’s stock price dropped 6% during mid-day trading on Thursday . The stock traded as low as $0.47 and last traded at $0.47. Approximately 500 shares traded hands during mid-day trading, a decline of 98% from the average daily volume of 20,342 shares. The stock had previously closed at $0.50.
Cell MedX Stock Down 6.0 %
The company has a 50 day moving average price of $0.34 and a 200-day moving average price of $0.13.
About Cell MedX
Cell MedX Corp., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson’s disease, high blood pressure, neuropathy, and kidney functions in the United States. The company develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual.
Featured Stories
- Five stocks we like better than Cell MedX
- How to Effectively Use the MarketBeat Ratings Screener
- 3 Defense Stocks Gaining From Budget and Interest Rate Pressures
- What is Put Option Volume?
- 3 Natural Gas Stocks Set to Thrive in This Winter’s Freeze
- 3 Warren Buffett Stocks to Buy Now
- Bullish on Athleisure? Here’s Why Lululemon Stock Shines
Receive News & Ratings for Cell MedX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cell MedX and related companies with MarketBeat.com's FREE daily email newsletter.
